These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12569302)

  • 1. Thioredoxin reductase and cancer cell growth inhibition by organotellurium antioxidants.
    Engman L; Al-Maharik N; McNaughton M; Birmingham A; Powis G
    Anticancer Drugs; 2003 Feb; 14(2):153-61. PubMed ID: 12569302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells.
    Engman L; Kandra T; Gallegos A; Williams R; Powis G
    Anticancer Drug Des; 2000 Oct; 15(5):323-30. PubMed ID: 11354308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
    Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
    Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thioredoxin reductase and cancer cell growth inhibition by organotellurium compounds that could be selectively incorporated into tumor cells.
    Engman L; Al-Maharik N; McNaughton M; Birmingham A; Powis G
    Bioorg Med Chem; 2003 Nov; 11(23):5091-100. PubMed ID: 14604673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth.
    McNaughton M; Engman L; Birmingham A; Powis G; Cotgreave IA
    J Med Chem; 2004 Jan; 47(1):233-9. PubMed ID: 14695837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thioredoxin reductase and cancer cell growth inhibition by organogold(III) compounds.
    Engman L; McNaughton M; Gajewska M; Kumar S; Birmingham A; Powis G
    Anticancer Drugs; 2006 Jun; 17(5):539-44. PubMed ID: 16702810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.
    Huang J; Xu J; Tian L; Zhong L
    Biochimie; 2014 Feb; 97():92-103. PubMed ID: 24103200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Thioredoxin System for Cancer Therapy.
    Zhang J; Li X; Han X; Liu R; Fang J
    Trends Pharmacol Sci; 2017 Sep; 38(9):794-808. PubMed ID: 28648527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal complexes with 2-acetylpyridine-N(4)-orthochlorophenylthiosemicarbazone: cytotoxicity and effect on the enzymatic activity of thioredoxin reductase and glutathione reductase.
    Parrilha GL; Ferraz KS; Lessa JA; de Oliveira KN; Rodrigues BL; Ramos JP; Souza-Fagundes EM; Ott I; Beraldo H
    Eur J Med Chem; 2014 Sep; 84():537-44. PubMed ID: 25058344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applying the designed multiple ligands approach to inhibit dihydrofolate reductase and thioredoxin reductase for anti-proliferative activity.
    Ng HL; Chen S; Chew EH; Chui WK
    Eur J Med Chem; 2016 Jun; 115():63-74. PubMed ID: 26994844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents.
    Liu Y; Li Y; Yu S; Zhao G
    Curr Drug Targets; 2012 Oct; 13(11):1432-44. PubMed ID: 22876886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition.
    Reiser K; Mathys L; Curbo S; Pannecouque C; Noppen S; Liekens S; Engman L; Lundberg M; Balzarini J; Karlsson A
    PLoS One; 2016; 11(1):e0147773. PubMed ID: 26816344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.
    Lu J; Chew EH; Holmgren A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12288-93. PubMed ID: 17640917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thioredoxin, thioredoxin reductase and tumour necrosis factor-alpha expression in melanoma cells: correlation to resistance against cytotoxic attack.
    Barral AM; Källström R; Sander B; Rosén A
    Melanoma Res; 2000 Aug; 10(4):331-43. PubMed ID: 10985667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
    Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
    Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma.
    Raninga PV; Di Trapani G; Vuckovic S; Tonissen KF
    Redox Biol; 2016 Aug; 8():175-85. PubMed ID: 26795735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species, antioxidants, and the mammalian thioredoxin system.
    Nordberg J; Arnér ES
    Free Radic Biol Med; 2001 Dec; 31(11):1287-312. PubMed ID: 11728801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
    Kaminska KK; Bertrand HC; Tajima H; Stafford WC; Cheng Q; Chen W; Wells G; Arner ES; Chew EH
    Oncotarget; 2016 Jun; 7(26):40233-40251. PubMed ID: 27244886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
    Prast-Nielsen S; Cebula M; Pader I; Arnér ES
    Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione.
    Lu J; Vlamis-Gardikas A; Kandasamy K; Zhao R; Gustafsson TN; Engstrand L; Hoffner S; Engman L; Holmgren A
    FASEB J; 2013 Apr; 27(4):1394-403. PubMed ID: 23248236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.